Allspring Global Investments Holdings LLC lessened its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 0.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,615,996 shares of the company's stock after selling 8,505 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 3.26% of Prestige Consumer Healthcare worth $138,539,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Geode Capital Management LLC lifted its position in shares of Prestige Consumer Healthcare by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company's stock worth $105,342,000 after purchasing an additional 21,951 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter valued at $84,932,000. Invesco Ltd. boosted its holdings in Prestige Consumer Healthcare by 2.4% in the fourth quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock valued at $82,796,000 after purchasing an additional 24,392 shares during the period. Congress Asset Management Co. grew its stake in Prestige Consumer Healthcare by 9.1% during the 1st quarter. Congress Asset Management Co. now owns 991,580 shares of the company's stock worth $85,246,000 after purchasing an additional 82,838 shares in the last quarter. Finally, Northern Trust Corp grew its stake in Prestige Consumer Healthcare by 10.9% during the 4th quarter. Northern Trust Corp now owns 813,076 shares of the company's stock worth $63,493,000 after purchasing an additional 80,055 shares in the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.
Prestige Consumer Healthcare Stock Up 0.5%
Shares of NYSE:PBH traded up $0.43 during trading on Tuesday, hitting $80.28. 560,796 shares of the company were exchanged, compared to its average volume of 303,984. The firm's 50 day moving average price is $84.16 and its 200-day moving average price is $82.43. Prestige Consumer Healthcare Inc. has a 12-month low of $64.94 and a 12-month high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82. The stock has a market capitalization of $3.97 billion, a P/E ratio of 18.71, a PEG ratio of 2.43 and a beta of 0.45.
Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. The firm had revenue of $296.52 million for the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The firm's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.02 EPS. On average, research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
PBH has been the topic of a number of analyst reports. Royal Bank Of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, May 17th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.
Read Our Latest Research Report on Prestige Consumer Healthcare
About Prestige Consumer Healthcare
(
Free Report)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Read More
Before you consider Prestige Consumer Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prestige Consumer Healthcare wasn't on the list.
While Prestige Consumer Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
